Cancer
is the uncontrolled and abnormal growth of cells that results in
formation of a mass called tumor. This tumor can be cancerous or
benign. Head and neck cancer is the terminology used to define a
number of different malignant tumors that develop in or around the
throat, larynx, nose, sinuses, and mouth. Furthermore, head and neck
cancers initiate in squamous cells, cells that line moist surfaces
such as those inside the head and neck (for example, the mouth, nose,
and throat). Salivary glands have different types of cells that can
turn cancerous. Chewing tobacco, excessive alcohol consumption, and
infection with human papillomavirus (HPV) increases the risk of head
and neck cancer. Other risk factors for head and neck cancers include
excessive consumption of paan (betel quid), preserved or salted
foods, oral health, occupational exposure, radiation exposure,
Epstein barr virus infection, and due to hereditary causes.
Request
For Sample Copy of This Research:
https://www.coherentmarketinsights.com/insight/request-sample/530
Need
for effective and targeted treatment is critical to increase the
survival rates
Treatment
of head and neck cancer is a major challenge for physicians, as the
affectivity and choice of treatment varies from patient to patient
and location of the tumor. Owing to complexity of facial structures
and functions limits the surgical treatments for head and neck
cancers, with surgery being the preferred mode of treatment.
Post-surgery, functions such as chewing, talking, and swallowing may
be adversely affected. Physicians opt for surgical therapy in
combination with radiation therapy for treatment of the malady.
Survival rate of head and neck cancer has reduced from 80% to 50% in
last ten years, as currently available treatment options mainly treat
the symptoms. Recent developments in the area of advanced
chemotherapy and radiotherapy permit preserving some of the functions
of the face. The introduction of targeted molecular therapy such as
gene therapy, monoclonal antibodies, and antibody drug conjugates
creates major growth avenues for the head and neck cancer market.
High
incidence rate creates a potential growth opportunity for the market
players
Growing
occurrence of head and neck cancer and increasing research activities
to develop cost-effective treatment options are the factors which are
driving growth of the global head and neck cancer market. According
to the World Health Organization, 3 - 5% of the population around the
globe suffers from head and neck cancer. Moreover, worldwide
approximately 550,000 new cases of head and neck cancer are diagnosed
annually with almost 300,000 deaths annually. While the cancer can
affect people across different age groups, it is especially prevalent
among people over 50 years of age. Head and neck cancer is projected
to result in 13,360 fatalities (3,420 women and 9,940 men) in 2017.
These types of cancers are more than twice as common among men as
women.
Global
Top Players -
Key
players operating in the head and neck cancer market are AB Science
SA, Bayer AG, Bristol-Myers Squibb Company, Acceleron Pharma, Inc.,
Astellas Pharma Inc., Boston Biomedical, Inc., AbbVie Inc., and
AstraZeneca Plc.
Head
And Neck Cancer Market Taxonomy -
On
the basis of disease indication, the global head and neck cancer
market is classified into:
-
Laryngeal and Hypopharyngeal Cancer
-
Nasal Cavity and Paranasal Sinus Cancer
-
Nasopharyngeal Cancer
-
Oral and Oropharyngeal Cancer
-
Salivary Gland Cancer
On
the basis of diagnostic methods, the global head and neck cancer
market is classified into:
-
Diagnostic imaging equipment
-
Endoscopy screening equipment
-
Bioscopy screening tests
-
Blood tests
-
Dental diagnostic
Browse
Full Research Report @
https://www.coherentmarketinsights.com/ongoing-insight/head-and-neck-cancer-market-530
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment